These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36104172)

  • 1. Towards tobacco-free retailers: feasibility of an intervention encouraging retailers to stop selling tobacco in Tasmania.
    Smith AL; Mihrshahi S; Martin-Gall VA; Brkic M; Veitch MG; Freeman B
    Tob Control; 2024 Apr; 33(3):317-324. PubMed ID: 36104172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding why some Australian retailers have stopped selling tobacco, some might and some are unlikely.
    Watts C; Burton S; Phillips F; Kennington K; Scollo M; Lindorff K; Egger S
    Tob Control; 2020 Dec; 29(e1):e63-e70. PubMed ID: 31484799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could We See the End of Tobacco Being Sold in Bars and Pubs in New Zealand?
    Marsh L; Iosua E; Quigg R; Brillinger J; Venter N; Wood S
    Nicotine Tob Res; 2022 Oct; 24(10):1669-1677. PubMed ID: 35417537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Tasmanian retailers stop selling tobacco and implications for tobacco control.
    Melody SM; Martin-Gall VA; Veitch MG
    Tob Control; 2021 Sep; 30(5):583-586. PubMed ID: 32769212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why California retailers stop selling tobacco products, and what their customers and employees think about it when they do: case studies.
    McDaniel PA; Malone RE
    BMC Public Health; 2011 Nov; 11():848. PubMed ID: 22067084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve smoking cessation rates in primary care.
    Lindson N; Pritchard G; Hong B; Fanshawe TR; Pipe A; Papadakis S
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011556. PubMed ID: 34693994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco Retailers' Support for Point-of-Sale Tobacco Control Policies in England: Association Study of Retailers' Perceived Importance of Tobacco Sales, Contact with the Tobacco Industry, and the Perceived Impact of the Policy.
    van Deelen TRD; Arnott D; Hitchman S; van den Putte B; Kunst AE; Kuipers MAG
    Nicotine Tob Res; 2022 Apr; 24(6):813-819. PubMed ID: 34850937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing weight gain after smoking cessation.
    Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.
    Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
    Baker RR; Pereira da Silva JR; Smith G
    Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying tobacco retailers in the absence of a licensing system: lessons from Australia.
    Baker J; Masood M; Rahman MA; Thornton L; Begg S
    Tob Control; 2022 Jul; 31(4):543-548. PubMed ID: 33526443
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.